These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 2975187

  • 1. Receptor characteristics and recovery of function following kainic acid lesions and fetal transplants of the striatum. II. Dopaminergic systems.
    Deckel AW, Moran TH, Robinson RG.
    Brain Res; 1988 Nov 22; 474(1):39-47. PubMed ID: 2975187
    [Abstract] [Full Text] [Related]

  • 2. Behavioral recovery following kainic acid lesions and fetal implants of the striatum occurs independent of dopaminergic mechanisms.
    Deckel AW, Moran TH, Robinson RG.
    Brain Res; 1986 Jan 22; 363(2):383-5. PubMed ID: 3002559
    [Abstract] [Full Text] [Related]

  • 3. Receptor characteristics and recovery of function following kainic acid lesions and fetal transplants of the striatum. I. Cholinergic systems.
    Deckel AW, Moran TH, Robinson RG.
    Brain Res; 1988 Nov 22; 474(1):27-38. PubMed ID: 3214714
    [Abstract] [Full Text] [Related]

  • 4. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat.
    Gagnon C, Bédard PJ, Rioux L, Gaudin D, Martinoli MG, Pelletier G, Di Paolo T.
    Brain Res; 1991 Sep 06; 558(2):251-63. PubMed ID: 1838295
    [Abstract] [Full Text] [Related]

  • 5. Fetal striatal tissue grafts into excitotoxin-lesioned striatum: pharmacological and behavioral aspects.
    Norman AB, Giordano M, Sanberg PR.
    Pharmacol Biochem Behav; 1989 Sep 06; 34(1):139-47. PubMed ID: 2626445
    [Abstract] [Full Text] [Related]

  • 6. Development of D1 and D2 dopamine receptors and associated second messenger systems in fetal striatal transplants.
    Helm GA, Robertson MW, Jallo GI, Simmons N, Bennett JP.
    Exp Neurol; 1991 Feb 06; 111(2):181-9. PubMed ID: 1703498
    [Abstract] [Full Text] [Related]

  • 7. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 06; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 8. Activation of striatal dopaminergic grafts by haloperidol.
    Herman JP, Choulli K, Le Moal M.
    Brain Res Bull; 1985 Dec 06; 15(6):543-6. PubMed ID: 3936594
    [Abstract] [Full Text] [Related]

  • 9. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM, Nurk AM.
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov 06; 67(11):1606-10. PubMed ID: 6799331
    [Abstract] [Full Text] [Related]

  • 10. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
    Bannon MJ, Bunney EB, Zigun JR, Skirboll LR, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun 06; 312(2):161-5. PubMed ID: 6772975
    [Abstract] [Full Text] [Related]

  • 11. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I, Kehr J, Andbjer B, Fuxe K.
    Exp Neurol; 2000 Jul 06; 164(1):154-65. PubMed ID: 10877926
    [Abstract] [Full Text] [Related]

  • 12. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
    Creese I, Burt DR, Snyder SH.
    Science; 1977 Aug 05; 197(4303):596-8. PubMed ID: 877576
    [Abstract] [Full Text] [Related]

  • 13. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease.
    Chen GJ, Jeng CH, Lin SZ, Tsai SH, Wang Y, Chiang YH.
    J Biomed Sci; 2002 Aug 05; 9(4):303-10. PubMed ID: 12145527
    [Abstract] [Full Text] [Related]

  • 14. Spontaneous and drug-induced locomotor activity after partial dopamine denervation of the ventral striatum.
    Carey RJ, Schwarting R.
    Neuropsychobiology; 1986 Aug 05; 16(2-3):121-5. PubMed ID: 3587570
    [Abstract] [Full Text] [Related]

  • 15. Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment.
    Zarkovsky AM, Nurk AM, Rägo LK, Allikmets LH.
    Neuropharmacology; 1982 Feb 05; 21(2):155-8. PubMed ID: 7199630
    [Abstract] [Full Text] [Related]

  • 16. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM, Hitri A, Goetz CG, Tanner CM, Klawans HL.
    Life Sci; 1988 Feb 05; 42(22):2207-15. PubMed ID: 3374255
    [Abstract] [Full Text] [Related]

  • 17. Effect of fetal striatal and astrocyte transplants into unilateral excitotoxin-lesioned striatum.
    Lu SY, Pixley SK, Emerich DF, Lehman MN, Norman AB.
    J Neural Transplant Plast; 1993 Feb 05; 4(4):279-87. PubMed ID: 7524691
    [Abstract] [Full Text] [Related]

  • 18. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS, O'Connor WT, Herrera-Marschitz M, Ungerstedt U.
    Brain Res; 1990 Jun 11; 519(1-2):255-60. PubMed ID: 1975763
    [Abstract] [Full Text] [Related]

  • 19. The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: A comparative study of lactacystin and 6-OHDA.
    Konieczny J, Czarnecka A, Lenda T, Kamińska K, Antkiewicz-Michaluk L.
    Neuroscience; 2017 Jan 06; 340():308-318. PubMed ID: 27826109
    [Abstract] [Full Text] [Related]

  • 20. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC, Brown GM, Jawahir G, Lee T, Seeman P.
    Am J Psychiatry; 1978 Jul 06; 135(7):839-41. PubMed ID: 665797
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.